Mental Disorder Clinical Trial
Official title:
A Magnetic Resonance Spectroscopy Study of Neuropsychiatric Effects Associated With Cytokines
Use of the drug interferon-alpha (IFN-A), is associated with frequent and well characterized
side effects like neurotoxicity. Neurotoxicity can cause symptoms of depression, agitation,
anxiety, and/or confusion.
The NIDDK is conducting a research study called, "Combination of Alpha Interferon with Long
Term Ribavirin Therapy for Patients with Chronic Hepatitis C" (98-DK-0003). Patients
participating in it are receiving interferon-alpha in addition to an antiviral medication
called ribavirin. Researchers at the NIMH intend to study patients to learn more about how
different medications can influence mood, thoughts and behavior.
The primary purpose of this study is to determine if treatment with IFN-A in combination
with ribavirin alters human brain biochemistry as measured by proton magnetic resonance
spectroscopy (MRS).
MRS uses strong magnetic fields in order to measure biochemical products of metabolism found
in the brain. Researchers intend to perform MRS scans before, during, and after patients
receive their medications
Researchers believe that the combination of IFN-A/Ribavirin will directly affect specific
areas of the brain and as a result, some patients will develop specific mood or cognitive
symptoms. Patients often must stop taking these medications because of the side effects.
This study will not contribute directly to the treatment of patient's Hepatitis C condition.
However, the information gathered from this study will help researchers better understand
the neuropsychiatric affects associated with interferon alpha and ribavirin therapy.
The systemic administration of interferon-alpha (IFN-A) is associated with frequent and well
characterized neuropsychiatric toxicity. The primary purpose of this study is to determine
if treatment with IFN-A in combination with ribavirin alters human brain biochemistry as
measured by proton magnetic resonance spectroscopy. The study population will be drawn from
subjects simultaneously enrolled in a NIDDK protocol (98-DK-0003) that employs IFN-A and
ribavirin for the treatment of hepatitis C virus (HCV) infection. Subjects will be evaluated
prior to IFN-A/ribavirin treatment and then followed prospectively with the specific aim of
identifying the emergence of central nervous system (CNS) effects. The principal outcome
measures will be as follows: determinations of specific brain metabolites as measured by
proton magnetic resonance spectroscopy (1H-MRS), a brief, non-invasive, and minimal risk
procedure; ratings of mood, cognitive, and behavioral symptoms.
The hypotheses being tested in this study are as follows:
1. Treatment with IFN-A/ribavirin will decrease measures of neuronal integrity (NAA/CRE
ratio) in a brain region specific fashion.
2. The degree of change in NAA/CRE in certain brain regions (e.g. prefrontal cortex) will
correspond to the development of mood or cognitive symptoms.
The questions being asked in this study are relevant to the clinical management of HCV
patients, since adverse neuropsychiatric effects of IFN-A and ribavirin frequently
complicate protocol participation and occasionally result in a subject being taken off
protocol. There are no anticipated number of patient days per year required for this study,
as all participants will be simultaneously enrolled in NIDDK protocol 98-DK-0003.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06102850 -
Adaptation of Critical Time Intervention for Young Adults With MH Challenges
|
N/A | |
| Completed |
NCT05649449 -
Testing Self-Directed Care in Florida
|
N/A | |
| Not yet recruiting |
NCT05886595 -
Being Young : My Mental Health
|
||
| Recruiting |
NCT04157062 -
An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder
|
N/A | |
| Completed |
NCT04505540 -
Start Treatment and Recovery for Opioid Use Disorder
|
N/A | |
| Withdrawn |
NCT03236766 -
Engaging Pacific Islander Perspectives on Mental Illness and Mental Health Services
|
N/A | |
| Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
| Not yet recruiting |
NCT04071145 -
Using Sensors to Measure Drug Concentrations in Exhaled Breath
|
||
| Completed |
NCT04457635 -
Effect of a 'Rapid-Return-to-work Program' in Mild Mental Disorders.
|
N/A | |
| Completed |
NCT01922258 -
Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
|
Phase 3 | |
| Recruiting |
NCT06054061 -
Evaluation the Efficacy "Think and Cope Positively" Program
|
N/A | |
| Completed |
NCT03118388 -
Engaging Homeless Youth in Vocational Training to Meet Their Mental Health Needs
|
Phase 2 | |
| Active, not recruiting |
NCT04196881 -
Effect of Attention Deficit Hyperactivity Disorder Knowledge Improvement Program on Male Primary School Teachers
|
N/A | |
| Terminated |
NCT04028609 -
Community Health Worker Intervention to Improve Post-Hospital Outcomes
|
N/A | |
| Active, not recruiting |
NCT03641664 -
FCT Study: Reducing the Need for Out-of-Home Placements
|
N/A | |
| Completed |
NCT05019937 -
Exploring Effectiveness and Mechanism of Change of an Implementation Strategy on Guideline Implementation in Schools
|
N/A | |
| Completed |
NCT03611998 -
Survivors of Sex Trafficking: Occupation-Based Interventions for Executive Functioning
|
N/A | |
| Active, not recruiting |
NCT04148508 -
App-based Mental Health Promotion in Young European Adults
|
N/A | |
| Completed |
NCT03704805 -
Effect of a Psychological Intervention on Antiretroviral Therapy and Mental Health Outcomes in HIV-positive Adults in Zimbabwe
|
N/A | |
| Recruiting |
NCT05087446 -
Effect of Early Assessment Team for Patients Referred to Outpatient Mental Health Care
|
N/A |